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Type 2 diabetes (T2D) is a major global health problem and prevention could be 
improved by identifying individuals at risk at an early stage, followed by preventive 
strategies, e.g., dietary modifications. Untargeted LC-MS metabolomics offers the 
possibility to identify predictive biomarkers that may improve risk prediction and dietary 
biomarkers that may facilitate investigation of diet-T2D relationships. However, 
untargeted metabolomics generates large-scale data, resulting in demanding data 
processing and statistical analyses preceding meaningful biological interpretation. 
The work presented in this thesis sought to develop bioinformatics tools for dealing 
with large-scale data generated from untargeted LC-MS metabolomics, to apply such 
tools to identify predictive metabolites of T2D and metabolites related to predefined 
healthy Nordic dietary indices, and to investigate whether such metabolites are associated 
with T2D risk in a Swedish population. 
Two novel R programming based packages were developed: ‘batchCorr’, a data-
processing strategy to correct for within- and between-batch variability in LC-MS 
experiments, and ‘MUVR’, a statistical framework for multivariate analysis with 
unbiased variable selection. These tools were applied on untargeted LC-MS 
metabolomics data obtained from plasma samples from a nested case-control study. 
Overall, 46 predictive metabolites of T2D were identified. Several metabolites showed 
good long-term reproducibility among healthy participants, reinforcing their potential as 
predictive biomarkers, while some changed in the disease-associated direction among 
cases, reflecting disease progression. In total, 38 metabolites were found to be associated 
with two predefined healthy Nordic dietary indices. No evidence was found to support 
association between indices and T2D risk. Instead, metabolites related to unhealthy foods 
not captured in indices were associated with increased risk.  
In conclusion, the novel bioinformatics tools developed here can overcome vital data-
analytical challenges inherent in large-scale untargeted metabolomics studies. Predictive 
metabolites have great potential to provide information related to T2D pathophysiology 
and monitoring of disease progression, though only a limited improvement in disease 
prediction was achieved when adding them to models based on optimally selected 
traditional risk factors. Moreover, no evidence was found of an association between 
healthy Nordic dietary indices and T2D risk. Future studies should investigate how 
diet/lifestyle risk factors affect pathological pathways of T2D and prevent disease 
development by integration of multi-omics techniques and traditional methods. 
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Diabetes is a chronic, progressive non-communicable disease and is an 
important cause of morbidity, mortality, and high healthcare costs worldwide 
(World Health Organization, 2016; Zhou et al., 2016). According to the latest 
report by the International Diabetes Federation (IDF, 2015, 
https://www.idf.org/), approximately 415 million adults have diabetes and 
by 2040 this number is estimated to rise to 642 million. In an effort to address 
this growing health challenge, one of the major goals of the 2030 Agenda for 
Sustainable Development is to reduce premature mortality from non-
communicable diseases, including diabetes, by one-third through prevention 
and treatment by 2030.  
Type 2 diabetes (T2D) constitutes about 90-95% of diabetes cases and is 
a metabolic disorder characterized by insulin resistance in target tissues and 
deficiency of insulin secretion in the pancreas (Hameed et al., 2015; World 
Health Organization, 2016). The etiology of T2D involves interactions 
between genetic predisposition and environmental factors, including diet, 
which has been suggested as an important factor that has a strong impact on 
the risk of developing T2D (AlEssa et al., 2017; Schwingshackl et al., 2017). 
The incidence of T2D could be effectively reduced if at-risk individuals who 
might benefit from effective and preventive therapies/interventions could be 
detected early (Zhang et al., 2013; World Health Organization, 2016). 
Therefore, understanding the biological mechanisms in T2D 
pathophysiology and identifying populations at risk are critically important. 
State-of-the-art analytical technologies and bioinformatics have boosted 
the development of ‘omics’ technologies, i.e., genomics, transcriptomics, 
proteomics, and metabolomics (Haring and Wallaschofski, 2012; Fondi and 
Liò, 2015). Among these techniques, metabolomics is a useful tool for 
analyzing physiological and disease-induced biological states at the 
1 Background 
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molecular level, taking into account both properties of the organism, such as 
genetic factors, health status, and other phenotypic traits, and the effects of 
environmental factors, e.g., diet, physical activity, and medication  
(Trifonova et al., 2013; Menni et al., 2017).   
Applications of metabolomics in T2D research have shown great 
potential to identify novel factors, i.e., metabolite biomarkers that relate to 
T2D development, thereby providing complementary information to 
established risk factors and facilitating personalized medical/nutrition 
interventions. Moreover, metabolomics is emerging as a key technology for 
identification of biomarkers that reflect the exposome, including dietary 
biomarkers, which provide a complement to error-prone self-reported dietary 
assessment (Scalbert et al., 2014; Cheung et al., 2017; Marushka et al., 
2017). The use of such biomarkers may also aid in investigation of the diet-
disease relationship (Biskup et al., 2016; Savolainen et al., 2017). 
1.1 The human metabolome and metabolomics 
The human metabolome can be defined as the complete set of low molecular 
weight compounds (<2000 Da), known as metabolites, that are present in 
cells, organs, tissues, or bio-fluids (Wishart et al., 2007). The metabolome 
represents the level downstream of genetic variation, transcriptional changes, 
and post-translational modifications of proteins, and is also influenced by 
environmental and lifestyle factors, e.g., diet, physical activity, 
microorganisms, and medications (Wishart et al., 2007; Wishart, 2016) 
(Figure 1). It includes a diverse group of intermediates and products of 
metabolism, such as lipids, amino acids, peptides, nucleic acids, organic 
acids, vitamins, and thiols. According to the latest report in the Human 
Metabolome Database (HMDB), more than 18,000 metabolites have been 
detected and quantified in human samples and the vast majority of these have 
been found in the blood (http://www.hmdb.ca/statistics). 
Metabolomics is defined as comprehensive analysis of metabolites in 
biological samples (Dunn et al., 2011; Menni et al., 2017). Different 
biological samples can be measured in a metabolomics study, with the 
research question driving the optimal selection of sample types. The 
commonly used samples in human studies are urine, plasma, serum, saliva, 
and biopsy samples.   
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Figure 1. Different 'Omics'. Factors influencing the human metabolome that could be measured by 
metabolomics. MW: molecular weight. 
1.1.1 Targeted and untargeted metabolomics 
Metabolomics studies often apply one of two fundamental approaches: 
targeted or untargeted analysis (Lazar et al., 2015; Gorrochategui et al., 
2016). These approaches are complementary. Targeted metabolomics aims 
to quantify a subset of pre-defined groups of chemically characterized and 
biochemically annotated metabolites (typically <200) based on a priori 
hypotheses. This approach leads to higher precision and the possibility to use 
absolute quantification of metabolites in samples. However, targeted 
metabolomics covers a limited number of metabolites, which may limit the 
scope to generate novel hypotheses.  
Untargeted metabolomics is an intended comprehensive analysis of ‘all’ 
measurable metabolites with the chosen technology in a biological sample, 
including unknown compounds (Gorrochategui et al., 2016). It provides a 
holistic view of the small molecules in the biological sample and has great 
potential for hypothesis-generating discovery studies. However, untargeted 
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metabolomics often results in a massively large amount of information-rich 
and complex data, which leads to challenges regarding unbiased and optimal 
strategies for data acquisition, data processing, and statistical analyses. It 
therefore requires sophisticated bioinformatics tools for interpretation of the 
results (Gorrochategui et al., 2016; Schrimpe-Rutledge et al., 2016). 
Moreover, identification of metabolites, in particular unknowns, is an 
essential, yet problematic and challenging, aspect of untargeted 
metabolomics studies (Dunn et al., 2013; Alonso et al., 2015).  
1.1.2 Analytical platforms for metabolomics 
Regardless of the approach used, the analytical techniques/platforms that 
have often been applied in metabolomics studies include nuclear magnetic 
resonance (NMR), and mass spectrometry (MS). Mass spectrometry is 
normally coupled to different separation techniques, in particular gas 
chromatography (GC) or liquid chromatography (LC), whereas direct 
analysis is most often performed with NMR(Dunn et al., 2011; Wishart, 
2016). Mass spectrometry and NMR are complementary and each have their 
advantages and disadvantages. Many reviews have comprehensively 
discussed how each of these techniques works and how each can be used in 
metabolomics(Alonso et al., 2015; Wishart, 2016). In brief, NMR has the 
advantages of simple sample preparation, non-destructive sample analysis, 
simultaneously detectable molecular species and excellent reproducibility, 
but has relatively low sensitivity, detecting only the most abundant 
compounds (typically >1 µmol/L) in a sample, whereas MS-based 
techniques are able to detect compounds in much lower concentrations 
(Wishart, 2016).  
Liquid chromatography-mass spectrometry (LC-MS) is gaining in 
popularity in the metabolomics field. High-performance liquid 
chromatography (HPLC) and ultra-HPLC (UHPLC) are considered more 
comprehensive than GC-MS, since they permit analysis of a broader range 
of metabolites, i.e., from peptides to hydrophilic organic acids, even to 
hydrophobic lipids, without sample derivatization (Wishart, 2016). Coupling 
LC to high-resolution mass spectrometry, such as time-of flight (TOF), 
quadrupole time-of-flight (QTOF), Fourier transform ion cyclotron 
resonance, and orbital ion traps, gives great specificity and sensitivity, 
thereby improving the quality of metabolome data. These advances allow 
LC-MS to be used for routine separation and measurement of thousands of 
discrete chemical features from large-scale sample sets in the untargeted 
fashion (Zhu et al., 2013; Gorrochategui et al., 2016; Rochat, 2016).  
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This thesis focuses on untargeted LC-MS metabolomics, since this was 
the technique of choice for all studies performed (Papers I-IV). 
1.2 Untargeted LC-MS metabolomics  
A typical untargeted metabolomics workflow constitutes several 
fundamental steps that need careful consideration, i.e., study design, sample 
preparation, data acquisition and storage, data processing and analysis, 
metabolite identification, and biological interpretation (Theodoridis et al., 
2008; Gorrochategui et al., 2016) (Figure 2). Challenges and detailed 
analytical aspects have been comprehensively reviewed in the literature, 
providing informative and valuable guidance for researchers (Dunn et al., 
2011; Yin and Xu, 2014; Yi et al., 2016; Dudzik et al., 2017). 
Figure 2. General workflow of untargeted metabolomics. MSI: Metabolomics Standards Initiative. 
The workflows indicated by dotted lines indicate alternate workflows where metabolites are 
identified and quantified prior to statistics. 
Applying LC-MS in large-scale studies, such as in epidemiological 
investigations with thousands of samples, generates complex data with an 
abundance of MS spectra for each observation and at all retention times (RT), 
which makes data processing and analysis a challenging task. Inappropriate 
data processing and analysis increases the risk of chance findings and 
misinterpretation. In addition, metabolite identification is indispensable in 
conferring biological meaning to the observed features in a MS-based 
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metabolomics study (Dunn et al., 2013; Alonso et al., 2015; Gorrochategui 
et al., 2016).  
Overall, translating metabolomics data into biologically meaningful 
information involves several steps: spectral processing, data normalization, 
downstream statistical analysis of processed datasets, and identification of 
the metabolites underlying the observed metabolic features.  
1.2.1 Spectral processing of LC-MS data 
Raw LC-MS data contain three dimensions: m/z (mass/charge ratio), RT, and 
signal intensity. Pre-processing is conducted to identify and quantify features 
and transform three-dimensional (3D) data into a 2D numerical dataset 
suitable for downstream analysis (Alonso et al., 2015). A feature refers to a 
molecular entity with a unique mass to charge ratio (m/z) and RT, with an 
intensity representing feature height or area. It is noteworthy that each 
feature can be a molecular ion, adduct, fragment, or isotope of a metabolite, 
and that one metabolite may be represented by several features. 
Raw data acquired by instruments can be processed using vendor software 
packages, such as Mass Profiler Professional (Agilent Technologies), 
DataAnalysis (Bruker Daltonics), and MarkerLynx™ (Waters Corporation). 
A number of open-source software tools have been developed, e.g., XCMS 
(Smith et al., 2006) and the MZmine packages (Katajamaa et al., 2006; 
Pluskal et al., 2010), due to their wider and more flexible practicality and 
feasibility (Myers et al., 2017; Spicer et al., 2017). Regardless of the 
software used, spectral processing typically includes algorithms for the two 
key steps, feature detection and alignment (Lazar et al., 2015; Gorrochategui 
et al., 2016).  
Feature detection 
Many algorithms have been proposed for feature detection (Tautenhahn et 
al., 2008; Gorrochategui et al., 2016). Among these, the continuous wavelet 
transform-based centWave algorithm implemented in the modular 
framework of widely used open source software packages, i.e., XCMS and 
Mzmine, is often used in the metabolomics community (Myers et al., 2017; 
Spicer et al., 2017). This algorithm processes the sample spectra individually 
and the features are identified using multiple detection thresholds applied to 
different parameters such as the signal-to-noise ratio, ppm according to mass 
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accuracy, and peak width according to the chromatographic feature width 
range.  
These parameters are suggested to be instrument-dependent and study-
specific (Eliasson et al., 2012; Libiseller et al., 2015; Ganna et al., 2016). 
Parameter setting has great impact on the number and quality of features 
identified (Ganna et al., 2016). Some strategies have been proposed to 
optimize the relevant parameters, e.g., isotopologue parameter optimization 
(IPO), which is dedicated to parameters specific to XCMS (Libiseller et al., 
2015). However, optimization of parameters is rarely reported in LC-MS 
based metabolomics studies, especially when the feature detection is 
performed by vendor-specific software.   
Alignment 
When analyzing multiple samples, undesired shifts in RT and m/z are often 
seen due to many factors such as environmental temperature, changes in 
stationary or mobile phase of the chromatographic system, complex sample 
matrix, and ion suppression (Smith and Ventura, 2013). Shifts in m/z and RT 
of features between analytical runs result in different extracted spectrum 
patterns for metabolites across samples and severely affect subsequent 
statistical analysis and further metabolite identification. Owing to the 
continuous mass axis calibration that is commonly applied during data 
acquisition, shifts in m/z are in general small and the magnitude may be 
within an acceptable range. In contrast, the differences in RT can be quite 
large and non-linear (Podwojski et al., 2009; Smith and Ventura, 2013) 
(Figure 3).  
Most importantly, the shifts in RT increase with increasing period of time 
between experiments and become much more severe between multiple 
analytical batches than within each batch (Podwojski et al., 2009) (Figure 3). 
This may increase the risk of misalignment and give rise to critical challenges 
regarding information loss and data processing, especially in large studies 
where data are often collected over long periods and analyzed in multiple 
batches.  
Although many alignment methods for LC-MS metabolomics data have 
been developed, and are summarized in the literature (see e.g. Smith and 
Ventura, 2013; Spicer et al., 2017), to the best of our knowledge there were 
no methods available to specifically address systematic misalignment across 
multiple batches before this thesis work. Therefore, we saw that there was an 
urgent need for improved alignment algorithms. 
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Figure 3. Retention time (RT) deviation for samples within an analytical batch (left) and between 
multiple analytical batches. The subsets of samples were randomly selected from samples analysed 
as part of the studies presented in Papers I-IV. Each colored line represents a different sample 
processed. Note that the RT deviation is different for each sample and that it is not linear. 
1.2.2 Data normalization  
Even when analytical procedures and spectral processing have been 
appropriately conducted, data will inevitably suffer from systematic and 
random variability in signal intensity, possibly due to matrix effects and/or 
variations in MS instrument sensitivity (Warrack et al., 2009; Brown et al., 
2011; Gorrochategui et al., 2016). Such variability adversely affects data 
quality and may hamper investigation of inherent biological variability of 
interest in the dataset (Mizuno et al., 2017). Therefore, normalization of LC-
MS data without artificially altering the biological differences between 
samples prior to statistics is of great importance (Sysi-Aho et al., 2007; Dunn 
et al., 2011; Mizuno et al., 2017).  
Several normalization approaches have been developed aiming to 
minimize signal drifts, including methods based on internal standards, total 
intensity, or intensity of the most stable features, signal intensity 
distributions (e.g., unit norm, median, and quantile), and quality control (QC) 
samples. Among these, QC sample strategies are most commonly applied 
(Dunn et al., 2012; Kirwan et al., 2013; Fernández-Albert et al., 2014; 
Petersen and Julia, 2015). The importance of QC samples and how they 
could be effectively applied for normalization of data have been well 
summarized (Dunn et al., 2011, 2012). In brief, QC samples are in general 
pooled samples under study, thereby having a similar matrix composition to 
the samples to be investigated. A sufficient number of QC samples should 
be processed together with study samples from preparation to data 
acquisition and data processing. Very often, QCs are injected randomly or 
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regularly within each analytical batch. In this way, QC samples provide a 
robust measure of the repeatability for each feature detected and allow 
effective correction for drifts within and between analytical batches (e.g., 
quality control-based robust LOESS signal correction) (Dunn et al., 2011, 
2012) (Figure 4). Following normalization, coefficient of variation (CV) for 
each single feature (CV <20%) and its frequency of presence in QC samples, 
i.e., the ‘80% rule’ (Smilde et al., 2005), are often used as criteria for 
determination of qualified features that are eligible for subsequent statistical 
analysis. 
Figure 4. Quality control-based robust LOESS signal correction. A correction procedure was 
applied for each feature. The shift correction algorithm implemented in R package ‘statTarget’ was 
performed on the example data with default setting (Luan H, 2016). 
1.2.3 Statistical methods applied in metabolomics 
Once a feature matrix that consists of qualified features has been produced, 
followed by feature-wise normalization (centering, scaling, and/or 
transformation) (van den Berg et al., 2006), one or multiple statistical 
analyses are subsequently performed to identify relevant and informative 
variables with biologically meaningful information (Broadhurst and Kell, 
2006; Xi et al., 2014).  
Metabolomics studies are often conducted to identify biomarkers of 
disease or biological processes (Brennan et al., 2015; Klein et al., 2016), to 
characterize complicated biochemical systems (Schmid and Blank, 2010; 
Fondi and Liò, 2015), and to reveal insights into the mechanism of 
pathophysiological processes (Tanaka and Ogishima, 2011; Barallobre-
Barreiro et al., 2013). In general, data derived from metabolomics 
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experiments are often subjected to one of three major statistical methods, i.e., 
regression (where dependent response variable(s) Y is/are continuous), 
classification, (where dependent response variable(s) Y, is/are categorical), 
and sometimes the analytical strategy needs to cope with dependent data 
structures, derived e.g., from repeated measures and/or cross-over 
experimental designs. Different situations require different univariate and 
multivariate statistical methods to analyze the data. 
Univariate analysis 
Univariate methods focus on independent changes in individual features 
without considering the presence of inter-correlations between features. Each 
feature is tested by a parametric test, e.g., Student’s t test and Analysis of 
variance (ANOVA), or corresponding non-parametric tests, e.g., Wilcoxon-
rank test and Kruskal-Wallis one-way ANOVA, which are preferable when 
assumptions for parametric methods are not met. Correction for multiple 
testing is necessary to protect against the probability of false positives, i.e., 
finding a statistically significant result by chance, due to multiple 
comparisons. This is a crucial step that should always be considered when 
dealing with metabolomics data (Vinaixa et al., 2012; Gorrochategui et al., 
2016). However, in metabolomics data, many features represent the same 
metabolite and several features can be artifacts caused by chemical and/or 
bioinformatics noise. Therefore, traditional multiple test correction methods, 
i.e. Bonferroni correction and false-discovery rate (FDR) (Alonso et al., 
2015; Chong et al., 2015) may be overly conservative. This may result in 
substantial loss of statistical power to detect truly differential features. 
Multivariate analysis 
Unlike univariate methods, multivariate analysis methods take the relations 
between variables into consideration, and can be classified into unsupervised 
and supervised methods. Detailed descriptions and discussions on the 
working principles of commonly used techniques are available in excellent 
reviews (Broadhurst and Kell, 2006; Zhang et al., 2014; Gromski et al., 
2015). With unsupervised methods, e.g., principal component analysis 
(PCA) and hierarchical clustering analysis, data patterns can be detected 
without considering their orchestrated or complementary behavior in relation 
to biological responses/processes.  
Supervised methods have been extensively applied in metabolomics 
studies to extract relevant information from datasets that involve large 
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amounts of qualified features relevant to specific research questions 
(Gromski et al., 2015; Ren et al., 2015). The main supervised techniques 
applied in metabolomics studies are partial least squares regression (PLS) or 
PLS discrimination analysis (PLS-DA) and random forest (RF) (Gromski et 
al., 2015; Afanador et al., 2016; Yi et al., 2016). Model over-fitting has 
emerged as one of the major problems related to application of supervised 
modeling. An over-fitted model describes random error or noise in addition 
to the underlying relationship under investigation, thereby substantially 
increasing the risk of false positive discoveries and consequently leading to 
erroneous conclusions and hypotheses (Broadhurst and Kell, 2006; Saccenti 
et al., 2014). Therefore, great efforts and particular attention are required to 
avoid model over-fitting.  
Cross-validation is one of the most popular approaches to optimize 
models (e.g., the number of components in PLS), to evaluate model 
performance, and to reduce model over-fitting (Bro et al., 2008; Filzmoser 
et al., 2009; Arlot and Celisse, 2010; Baumann and Baumann, 2014). The 
repeated double cross-validation (rdCV) algorithm has been shown to 
achieve better performance in model optimization and in reducing the risk of 
over-fitting (Filzmoser et al., 2009) than leave-one-out and K-fold cross-
validation.  
Variable selection aims to generate a compact data structure with less 
noisy and redundant predictors, which facilitates production of parsimonious 
models that exhibit robust explanatory predictive power and minimized over-
fitting (Saeys et al., 2007; Barbu et al., 2013; Rudnicki et al., 2015). Most 
existing variable selection techniques are designed to identify the ‘minimal-
optimal’ variables set, i.e., maximum information density per variable, while 
optimizing prediction performance (Rudnicki et al., 2015). This strategy is 
particularly useful for e.g., designing diagnostic, predictive, or prognostic 
biomarkers (Nilsson et al., 2007; Saeys et al., 2014). However, only a limited 
number of algorithms have been tailored for identifying the ‘all-relevant’ 
variable set (Kursa and Rudnicki, 2011). This strategy facilitates 
understanding of complicated biochemical systems or mechanisms of e.g., 
pathophysiological or metabolic processes, where all changes in the 
metabolites in relation to research questions are of interest. 
Several studies have applied variable selection to construct robust models 
(Gromski et al., 2014; Bujak et al., 2016; Grissa et al., 2016). However, 
many of these have suffered from selection bias, which in turn induces over-
optimistic estimations and an increasing risk of false positive discoveries due 
to over-fitting (Ambroise and McLachlan, 2002; Krawczuk and Lukaszuk, 
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2016). Selection bias occurs when a given dataset is used for both variable 
selection and assessment of model performance. To address this issue, a few 
variable selection-within-validation schemes have been introduced. For 
example, Boulesteix et al. (2007) propose implementation of variable 
selection based on the Wilcoxon test within a Monte Carlo CV scheme to 
avoid biased estimation, but this algorithm can only be used for classification 
analysis. Goodacre et al. (2011) have developed a generic algorithm based 
on a Bayesian network approach, which assesses the predictive accuracy on 
a test set which was held out during model training and variable selection. 
The variable selection-within-validation schemes are highly recommended 
and outperform other bias-prone strategies. However, the scarcity of freely 
available, easy-to-use algorithms is a limiting factor. Therefore, easy-to-use 
software tools that support a wide range of comprehensive supervised 
modeling operations with proper validation are necessary for widespread 
implementation of these tools, which will ultimately have a major impact on 
the quality of metabolomics data.  
1.2.4 Metabolite identification 
A great potential in untargeted metabolomics is the discovery of novel 
molecular species, possibly unknown compounds, that are statistically 
associated with specific biological outcomes. This requires identification of 
metabolite(s) of interest. The commonly applied strategy for metabolite 
identification is to match the neutral molecular mass or m/z of a potential 
metabolite to its fragmentation pattern obtained by a tandem MS technique 
and compare the outcome against public databases, authentic standards, 
and/or published literature using a tolerance window for any deviation in 
mass accuracy (e.g. ppm threshold ranges from 5-30). The widely used open 
databases and their main characteristics are summarized in the literature 
(e.g., Lazar et al., 2015). Examples of compound-centric databases are e.g., 
HMDB, lipidMaps, Metlin.  
The Metabolomics Standard Initiative (MSI) reporting standards have been 
used to standardize the confidence level of metabolite identification over a 
decade (Spicer et al., 2017). The MSI defines four different levels of 
metabolite identification: Level 1 (highest level of identification) is 
identified metabolites that must be compared to an authentic chemical 
standard analyzed in the same laboratory, using the same analytical 
techniques as the experimental data. Level 2 and 3 are putatively annotated 
compounds and compound classes, respectively, that require matching to 
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databases rather than authentic chemical standards, while Level 4 is 
unknown compounds. A more stringent reporting criterion proposed recently 
that splits MSI reporting standards into 5 levels, though this is not commonly 
complied with (Schymanski et al., 2014). Great efforts are still required to 
reassess and update the reporting standards to fit the current community 
needs and benefit all investigators(Spicer et al., 2017).  
Chemical identification of unknown compounds represents a major 
challenge in untargeted metabolomics (Dunn et al., 2013; Schrimpe-
Rutledge et al., 2016). The neutral molecular mass is inferred from the 
molecular ion m/z value, and depends on e.g., ionization mode (H+ or H-), 
ionization adducts (e.g., Na+, K+, NH4+), and fragments that are common 
neutral losses, such as H2O, CO2, and HCOOH. Querying databases for a 
single peak m/z value may lead to multiple plausible neutral molecular 
masses, which increases false positive annotations and the workload in 
querying precursor ions in databases (Dunn et al., 2013; Alonso et al., 2015).  
To address this issue, several tools have been developed, e.g., 
PUTMEDID-LCMS (Brown et al., 2011) and CAMERA (Kuhl et al., 2014), 
to provide putative annotations for a panel of features deriving from the same 
compound, e.g., molecular ions, isotopes, adducts, and in-source 
fragmentations (Figure 5). 
Putative annotation normally relies on accurate m/z, m/z differences, RT 
similarity, pairwise correlation between measured responses, known adduct 
lists, and similarity of chromatographic peak shape. Automated annotation 
reduces the number of features to be considered for identification, increases 
querying efficiency, and provides an unequivocal molecular formula and/or 
putative identification. It is noteworthy that such annotation depends on the 
strength of correlations between measured features within a small RT 
window. However, the presence of misalignment due to the RT shifting and 
variability in signal intensity correlation across analytical runs may influence 
the correlations between features, thereby leading to false positive 
annotations and/or different annotations.  
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Figure 5. Example of putative annotation of some randomly chosen features using R package 
‘CAMERA’ (a) and PUTMEDID-LCMS (b). a) Extracted ion chromatograms (EIC) of labelled, 
putatively annotated peaks from one pseudospectrum, potentially representing a metabolite, at 
retention time 300 seconds. b) Key information on annotation using PUTMEDID-LCMS. Peaks 
with the same ID may originally come from one metabolite. A/F denotes possible annotated adducts 
or fragments. 
Recently, new strategies/pipelines in cooperation with advanced 
bioinformatics tools for metabolite identification tasks have emerged 
(Benton et al., 2015; Dührkop et al., 2015; Bingol et al., 2016; van der Hooft 
et al., 2016; Kouassi Nzoughet et al., 2017). These approaches may enable 
accurate, reliable, and rapid identification of metabolites in complex 
mixtures, but need to be validated in further studies.  
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1.3 Metabolomics for prediction of T2D  
Diagnosis of T2D is generally made on the basis of glucose and/or 
hemoglobin A1c concentrations in the blood. According to the American 
Diabetes Association (ADA) criteria, the diagnosis for diabetes is based on 
elevated fasting plasma glucose (FPG) (≥7.0 mmol/L) or elevated 2-hour 
plasma glucose (2h-PG) level (≥11.1 mmol/L) in an oral glucose tolerance 
test (OGTT) or elevated HbA1c level (≥6.5%) (American diabetes 
association, 2010). The current World Health Organization (WHO) 
diagnostic criterion for diabetes is FPG ≥ 7.0 mmol/L (126 mg/dL) or 2h-PG 
≥11.1 mmol/L (200 mg/dL). Diabetes symptoms (e.g., polyuria and 
polydipsia) also need to be considered. For people who do not show 
symptoms, diagnosis requires confirmatory plasma venous determination. At 
least one additional glucose test result on another day with a value in the 
diabetic range is needed for diagnosis, either fasting, from a random blood 
sample, or from the 2h-PG (WHO, 2006). 
A major shortcoming of the glucose-based diagnosis strategy is the poor 
sensitivity, resulting in late disease discovery when complications have 
already arisen, which have detrimental effects on human quality of life and 
longevity (Gjesing and Pedersen, 2012; Olokoba et al., 2012; World Health 
Organization, 2016). Given the increasing burden of the condition 
worldwide, earlier identification of at-risk individuals is of particular 
importance.  
1.3.1 Established risk factors for T2D 
T2D is multifactorial disease caused by a complex interplay between genetic 
and environmental factors (Temelkova-Kurktschiev and Stefanov, 2011; 
Abdullah et al., 2017; Läll et al., 2017). Several genome-wide association 
studies have identified hundreds of common variants associated with T2D 
(Temelkova-Kurktschiev and Stefanov, 2011; Läll et al., 2017). Despite high 
heritability (26-69%), the effects of genetic determinants may interact with 
other risk factors, e.g., lifestyle factors (physical inactivity, unhealthy dietary 
intake, tobacco use), thus providing relatively weak independent prediction 
power (Franks and McCarthy, 2016).  
Known risk factors have been incorporated into risk scores that are 
suggested for use as a practical screening tool to identify at-risk individuals 
for further testing among populations, such as the Diabetes Risk Score 
(Lindström and Tuomilehto, 2003), RuralDiab risk score (Zhou et al., 2017), 
and Framingham Risk Score. Despite moderate to good prediction in some 
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studies, models with established risk factors still leave room for 
improvement in risk prediction (Herder et al., 2014). Furthermore, 
established risk factors provide limited evidence of early mechanisms in 
relation to development of T2D.  
1.3.2 Metabolomics to identify predictive biomarkers 
Metabolomics has been successfully applied in a number of epidemiological 
studies, in particular in prospective study settings, to identify early metabolic 
alterations associated with a risk of developing T2D (Dunn, 2012; Lu et al., 
2013; Zhang et al., 2013; Gonzalez-Franquesa et al., 2016; de Mello et al., 
2017).  
There is a growing body of evidence, mostly from targeted metabolomics, 
on various species of metabolites that predict future T2D. Such metabolites 
include sugars, e.g., glucose, fructose, and hexose; branched-chain and 
aromatic amino acids (BCAA and AAA); free fatty acids and ketones, i.e., 
hydroxybutyrate, acetone, and acetoacetate originating from fatty acid 
oxidation; and lipids and their metabolic by-products, such as 
diacylglycerides, ceramides, choline-containing phospholipids (Lu, 2013; 
Gonzalez-Franquesa, 2016; Klein et al., 2016). The causative effect and 
underlying mechanism have yet to be clearly elucidated, but circulating 
concentrations have been shown to be altered 3-15 years before clinical 
diagnosis of T2D (see e.g., Herder et al., 2014; Klein and Shearer, 2016). 
Before the research presented in this thesis, few prospective studies had 
applied untargeted metabolomics for discovery of predictive metabolites, 
due to the high cost and complexity of robust large-scale metabolomics 
instrumental and data analyses. During the past four years, and benefiting 
from the rapid development of analytical techniques and bioinformatics 
tools, an increasing number of applications of untargeted metabolomics have 
uncovered novel metabolites associated with future T2D (Menni et al., 2013; 
Drogan et al., 2014; Nikiforova et al., 2014; Zhao et al., 2015; Fall et al., 
2016; Qiu et al., 2016; de Mello et al., 2017).  
Typical problems related to studies in the field include small number of 
incident cases, lack of generalizability, and/or ambiguous metabolite 
annotation by only matching molecular mass against online databases. It is 
also worth mentioning that most novel findings are study-specific and thus 
need to be further validated through independent studies. In addition, few 
studies assessed long-term reproducibility of identified metabolites (their 
fluctuations within individual over time). In most observational studies, 
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metabolites have been determined in a single sample at baseline, assumed to 
reflect the average concentration in an individual over time. However, 
metabolites are in fact subject to both random and systematic variations over 
time, particularly those metabolites that are related to disease. Random intra-
individual variability of a measured biomarker over time will affect the 
precision in risk estimates linking biomarker to endpoint and drive 
associations towards the null (Mcdermott, 1997). Reproducibility is 
therefore an important characteristic determining the applicability of 
metabolites in clinical investigations that needs to be investigated. The 
intraclass correlation coefficients (ICC), ranging between 0 and 1, is a 
typically used index of reproducibility. In general, ICC value 0.4–0.75 
indicates moderate to good reproducibility (Rosner, 2005; Carayol et al., 
2015).  
1.3.3 Incremental value of predictive metabolites in T2D risk prediction  
Several studies have investigated whether incorporation of metabolites 
together with established risk factors can improve T2D risk prediction 
(Herder et al., 2014; Yao et al., 2015; Zhao et al., 2015; Lu et al., 2016; 
Yengo et al., 2016; Peddinti et al., 2017).  
The most common method used to assess prediction power is the receiver 
operating characteristic (ROC) curves approach (Figure 6). The ROC is 
created by plotting the true positive rate (sensitivity) against the false 
positive rate (1-specificity) for measuring discrimination of a binary variable 
(case compared with control). For comparison between models, the area 
under the curve (AROC) is calculated. AROC varies between 0 and 1, where 
1 indicates perfect discrimination and 0.5 represents no discrimination. An 
AROC of 0.8 corresponds to 80% likelihood that a randomly selected case 
(i.e., a person who will develop disease) will be assigned a higher estimated 
diabetes risk than a randomly selected control (i.e., a person who will remain 
disease-free).  
The net reclassification improvement (NRI) is more sensitive for 
assessing the incremental predictive power of a new marker than AROC 
(Herder et al., 2014), where a large NRI value indicates good predictive 
ability. The integrated discrimination improvement (IDI) is another useful 
measure, with an IDI value of 0 meaning no predictive improvement. To 
assess the incremental value of a new predictor marker, use of all three 
measures is recommended to enhance the certainty of assessments(Herder et 
al., 2014). 
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Figure 6. Receiver operating characteristic (ROC) curves and area under the curves (AROC) from 
conditional logistic regression of T2D status including body mass index (BMI) and fasting plasma 
glucose (FPG; AROC=0.87) or additionally including 2h-plasma glucose (2h-PG; AROC=0.91). 
Data on BMI, fasting glucose and 2h-PG from the human studies in Papers I-IV were used. Perfect 
prediction would be a point in the upper left corner with coordinates (0,1) of the ROC space, 
representing 100% sensitivity (no false negatives) and 100% specificity (no false positives). A 
random classification would give a point along the diagonal line of no-discrimination. The p value 
relates to the difference in AROC between the two models. The addition of 2h-PG resulted in NRI 
(category-free) [95% CI]: 0.72 [0.61-0.84] and IDI [95% CI]: 0.1 [0.08-0.11] (p<0.05 for both 
measurements), indicating improvement in risk prediction. In this example, the same data were 
used to train and predict the model. 
1.4  Metabolomics to identify dietary biomarkers linking 
diet to T2D 
Diet has been associated with the risk of developing T2D (Alhazmi et al., 
2014; Schwingshackl et al., 2017). To improve understanding of the diet-
disease relationship, objective assessment of dietary intake of various types 
of foods in free-living populations is imperative, but is still a major challenge 
in nutritional science (Garcia-Perez et al., 2017). Metabolomics offers great 
possibilities to objectively reflect dietary exposures, and could also link such 
exposures to biological effects of relevance for disease development 
(O’Gorman and Brennan, 2015; Playdon, Ziegler, et al., 2017; Savolainen et 
al., 2017).  
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1.4.1 Epidemiological evidence for the association between diet and 
T2D 
Epidemiological studies have shown a protective role of individual foods 
such as whole grains, fish, vegetables, fruits, and coffee in developing T2D 
(Schwingshackl et al., 2017). In contrast, a poor-quality diet, characterized 
by high consumption of e.g., red/processed meat, high-sugar snacks, and soft 
drinks, has been associated with an increased risk (Pan et al., 2011; 
Schwingshackl et al., 2017).  
Humans consume combinations of foods, i.e., a diet. Analysis of 
individual foods however does not take the complexity of the entire diet, 
including interactions into consideration. Dietary pattern analysis has been 
suggested as an approach to provide a snapshot of the entire diet, considering 
extensive interaction between foods, which may be more informative in 
investigating diet-disease relationships than single food item analysis 
(Alhazmi et al., 2014; Osonoi et al., 2015). Two main approaches have been 
used to determine dietary patterns: dietary indices that assess compliance 
with a priori-defined dietary patterns, such as Mediterranean Diet Score 
(MDS) (Panagiotakos et al., 2006), Dietary Approaches to Stop 
Hypertension (DASH) score (Sacks et al., 1995), Healthy Eating Index 
(HEI)(Kennedy et al., 1995); and data-driven approaches, e.g., principal 
component analysis (PCA) and cluster analysis, which describe actual intake 
patterns in the population (Cespedes and Hu, 2015).  
Many studies have found that higher adherence to healthy dietary 
patterns, e.g., MDS and DASH, is associated with a reduced risk of 
developing T2D (De Koning et al., 2011; Abiemo et al., 2012; Jacobs et al., 
2017). In recent randomized controlled trials, adherence to a healthy Nordic 
dietary pattern was shown to have beneficial effects on cardio-metabolic risk 
factors (Adamsson et al., 2011, 2014; Damsgaard et al., 2012; Uusitupa et 
al., 2013; Poulsen et al., 2014). A healthy Nordic dietary pattern is 
characterized by traditional Nordic food items with potential health effects, 
such as vegetables, fish, fruits, berries, whole-grain rye and oat products, and 
various seafood products. However, epidemiological evidence regarding the 
role of a healthy Nordic dietary pattern for prevention of T2D is limited 
(Kanerva et al., 2014; Lacoppidan et al., 2015).  
1.4.2 Metabolomics to identify dietary biomarkers 
Most evidence on the role of diet in relation to T2D comes from 
epidemiological studies where food intake is typically based on self-
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reporting measurements by food frequency questionnaires (FFQ). However, 
such studies are subject to systematic and random measurement errors, e.g., 
due to misreporting and poor information from databases (Paeratakul et al., 
1998; Streppel et al., 2013). These errors contribute to data inaccuracy and 
may thus hamper the discovery of existing diet-disease relationships or lead 
to false positive associations (Paeratakul et al., 1998).  
Measuring dietary biomarkers in biological samples has been suggested 
as a complementary approach to self-reported methods to improve nutritional 
epidemiological studies ( Scalbert et al., 2014; Zheng et al., 2014; Brennan, 
2015; O’Gorman, 2015; Gibbons et al., 2017). Dietary biomarkers should 
objectively reflect the intake of a specific dietary exposure and can be used 
to validate self-reported measurements and/or be linked to disease endpoints 
(Hedrick et al., 2012; Scalbert et al., 2014; Bordoni and Capozzi, 2015). For 
validation and calibration of self-reported methods, recovery biomarkers are 
most useful. Such biomarkers reflect the intake, quantitatively, on the same 
scale and are not affected by non-dietary determinants to a large extent. 
Unfortunately, only a few recovery biomarkers exist (Freedman et al., 2010; 
Van Dam and Hunter, 2012). Most dietary biomarkers fall into the category 
of concentration biomarkers (Freedman et al., 2010). Such biomarkers 
represent a concentration in a biological tissue or fluid that is correlated with 
intake, but also affected by other determinants (Van Dam and Hunter, 2012).   
Metabolomics has emerged as a key technology for discovery and 
validation of dietary biomarkers that could objectively reflect food 
consumption (Gibbons and Brennan, 2017). Such biomarkers belong to the 
concentration biomarkers. Biomarker discovery studies can be made in 
controlled intervention settings or in cross-sectional observational studies 
(Scalbert et al., 2014). Of note, dietary biomarkers that were discovered in 
intervention studies may not be specific for the food under study at 
population level, because habitual diets may include other foods containing 
precursors of the same biomarkers. Thus, identifying diet-metabolite 
associations in observational studies is a complementary strategy to 
overcome this problem (Scalbert, 2014; Garcia-Perez, 2017; Gibbons and 
Brennan, 2017; Playdon et al., 2017). 
Metabolomics may also be used to provide objective assessments of 
overall dietary patterns in free-living populations (Garcia-Perez et al., 2017; 
Playdon et al., 2017). However, few biomarkers reflecting adherence to 
dietary patterns derived either by data-driven methods or a priori defined 
pattern indices exist (Floegel et al., 2013; Esko et al., 2017; Garcia-Perez et 
al., 2017; Playdon et al., 2017). 
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1.4.3 Dietary biomarkers linking diet with risk of T2D 
Dietary biomarkers could be used for investigation of associations between 
diet and T2D in large population-based cohort studies. Plasma 
alkylresorcinols represent a good example of dietary biomarkers that 
specifically reflect whole-grain wheat and rye intake (Landberg et al., 2008, 
2014; Kyrø et al., 2014; Biskup et al., 2016). The alkylresorcinol C17:0/ 
C21:0 ratio could reflect relative whole-grain rye to whole-grain wheat 
intake, and has been associated with improved insulin sensitivity and reduced 
risk of developing T2D  (Biskup et al., 2016).  
Very recently, Savolainen et al. (2017) analyzed and linked previously 
known dietary biomarkers with future T2D in a nested case-control study 
where self-reported dietary intake data were lacking. The multiple 
biomarkers captured different dietary components and suggested a lowered 
risk of developing T2D related to high concentrations of biomarkers 
previously shown to reflect fish, whole grains, vegetable oils, and good 
vitamin E levels, while biomarkers that reflected red meat and saturated fatty 
acids were associated with increased risk (Savolainen et al., 2017).  
However, no previous study has examined whether metabolites related to 
a specific dietary pattern are associated with incident T2D.  
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The overall aims of this thesis were to develop bioinformatics tools for data 
processing and analysis of large-scale untargeted LC-MS metabolomics and 
to apply such tools to identify predictive metabolites of T2D, to identify 
metabolites associated with a priori defined healthy Nordic dietary indices, 
and to investigate whether such metabolites are associated with risk of 
developing T2D in a Swedish nested case-control study.  
The specific objectives addressed through the thesis: 
(1) To develop a novel data-processing strategy to correct for within- and 
between-batch variability in processing multiple-batch untargeted LC-MS 
metabolomics data and to provide unbiased measures of improved data 
quality (Paper I). 
(2) To develop a novel statistical framework for multivariate modeling with 
unbiased variable selection aiming to identify informative variables from 
large-scale and high-dimensional datasets without compromising predictive 
accuracy and/or increasing the risk of over-fitting (Paper II). 
(3) To identify plasma metabolites that predict future T2D, and assess the 
extent to which inclusion of predictive metabolites beyond traditional risk 
factors could improve risk prediction. Further, to investigate the changes 
over time in identified metabolites among healthy individuals (i.e., 
reproducibility) and individuals who later developed T2D (i.e., systematic 
change reflecting disease progression) (Paper III). 
(4) To identify plasma metabolites associated with adherence to a healthy 
Nordic dietary pattern by two a priori-defined indices, the Baltic Sea Diet 
(BSDS) and the Healthy Nordic Food Index (HNFI), and to investigate 
associations of identified metabolites and the risk of T2D (Paper IV). 
2 Aims of the thesis 
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3.1 Study design and samples 
3.1.1 Participants and samples from the Västerbotten Intervention 
Programme cohort (Papers I, III, IV) 
Data and fasting plasma samples were obtained from the Västerbotten 
Intervention Programme (VIP) cohort, which is one of the sub-cohorts of the 
Northern Sweden Health and Disease Study cohort (Norberg et al., 2010). 
The cohort included 141,000 sampling occasions involving 98,300 
individuals by March 2015, of which 36,100 individuals have provided 
repeated samples. Recruitment for the VIP cohort started in 1985. 
Individuals at age 30, 40, 50, and 60 years were invited to participate in a 
systematic risk factor screening program, including individual counseling 
about lifestyle habits, at their local healthcare center. Blood samples were 
drawn and stored at the Northern Sweden Medical Biobank. In all 
assessments, all participants were asked to complete a questionnaire that 
captured information on socio-economic conditions, self-rated health, 
personal health history, and family history of diabetes, tobacco use, and 
physical activity.  
Incident T2D cases were identified according to the diabetes registry 
DiabNorth (Rolandsson et al., 2012). Among cases, participants that had an 
unthawed fasting plasma sample in the biobank and/or had follow-up 
samples available were considered eligible for this thesis work. Among 
eligible cases, 503 participants who developed T2D after a median time of 
seven years after baseline were selected (Figure 7a). Each case was 
individually matched to one non-diabetic individual according to age (+-2 
3 Materials and methods 
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years), gender, ethnic group, and season of blood draw. Among the 503 pairs 
of selected participants, 187 case-control pairs had a second follow-up 
sample drawn and data collected 10 years after baseline (Figure 7b). The 
corresponding characteristics of the subgroup of 187 case-control pairs with 
follow-up data were similar to those of the 503 case-control pairs and those 
without available repeated samples. The study protocol was approved by the 
Regional Ethics Committee in Uppsala, Sweden (registration number 
2014/011). 
Figure 7. Study design and population selection for the human studies reported in Papers III-IV. 
a) Flowchart of participant selection from the VIP cohort. b) Information on baseline and 10-year 
follow-up sampling among 187 type 2 diabetes cases.  
3.1.2 Diet data and healthy Nordic dietary pattern indices 
Two modified and validated versions of the Northern Sweden Food 
Frequency Questionnaire (FFQ) were used in the VIP cohort: one with 84 
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food items and another with 64 items (Johansson et al., 2002, 2010). Food 
items were energy-adjusted by the density method for dietary pattern indices 
(Playdon, Moore, et al., 2017). Two participants with an implausible caloric 
intake (<600 or >5000 kcal/day) and/or incomplete food frequency 
questionnaire (≥10% missing values) were excluded.  
Baltic Sea Diet Score (BSDS) was derived based on the approach 
described by Kanerva et al. (2014). The BSDS included nine food 
component categories (Table 1). All components, except alcohol, were 
scored according to sex-specific population consumption quartiles (Q1-Q4). 
For fruits, vegetables, whole-grain cereals, low-fat milk products, fish and 
FR, a score of 0-3 was given for Q1-Q4, while for meat products and total 
fat, the score was given in the reversed order. Alcohol scored 1 if intake was 
less than 20 g/day for men or 10 g/day for women, or otherwise a score of 0 
was given. The resulting BSDS ranged from 0 to 25 points, with higher 
scores representing stronger adherence to a healthy diet.  
The Healthy Nordic Food Index (HNFI) was calculated according to 
Olsen et al. (2011), and was initially based on six food items: fish, cabbages, 
rye bread, oatmeal, apples/pears, and root vegetables. However, since 
consumption of ‘rye bread’, ‘apples/pears’, and ‘oatmeal’ was not assessed 
specifically by these FFQs, ‘whole-grain bread’, ‘fruits (apples, pears, 
oranges, mandarins, grapefruits)’, and ‘oat/rye/barley porridge’ were used 
instead as respective proxy measures (Table 1). Adherence to the index was 
calculated by summarizing indices, where each food item was scored 0 or 1 
when intake was less than or greater than the sex-specific median intake of 
participants. The HNFI ranged from 0-6 and a higher score was indicative of 
stronger adherence to a healthy diet. 
Table 1. Food components involved in a priori-defined healthy Nordic dietary pattern indices 
Food components of dietary index Food items used to define the food component 
Baltic Sea Diet Score(BSDS) 
Nordic fruits Apples, pears, berries, oranges, mandarins, grapefruits 
Nordic vegetables Tomatoes, cucumbers, brassicas, legumes, carrots 
Nordic whole-grain cereals Whole-grain rye/wheat bread, rye, oat, barley porridge 
Fish Perch, cod, herring, salmon, white fish, shellfish 
Red and processed meat Beef, pork, processed meat and sausages 
Low-fat milk products Milk with 0.5% fat, yogurt with ≤3% fat 
Fat ratio (FR) Ratio of polyunsaturated fatty acids to sum of saturated 
fatty acid and trans-fatty acids 
Alcohol Alcohol 
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Food components of dietary index Food items used to define the food component 
Total fat Total fat 
Healthy Nordic Food Index(HNFI) 
Fruits Apples, pears, oranges 
Whole-grain bread Whole-grain rye/wheat bread 
Oat/rye/ barley porridge Whole-grain rye, oat, barley bread, porridge 
Fish Perch, cod, Baltic herring, salmon, white fish, shell fish 
Cabbages Cabbages 
Root vegetables Carrots 
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3.1.3 Datasets used for developing a statistical framework for 
multivariate modeling 
‘Freelive’: Detailed information on study design and metabolomics data 
acquisition has been described elsewhere (Hanhineva, Brunius, et al., 2015). 
In brief, free-living participants with no diagnosed or perceived 
gastrointestinal diseases or symptoms were invited to participate and 
instructed to adhere to their habitual diet. Untargeted LC-qTOF-MS 
metabolomics was performed on urine samples from 58 participants who 
completed three-day weighed food records, morning spot urine tests, and 24 
h urine collection on two separate occasions (periods A and B) 
approximately 2-3 months apart. The dataset consisted of reported whole-
grain rye consumption (continuous Y variable) from 112 observations (58 
unique participants; 2 individuals had sample from one occasion available), 
codes for individual (numeric ID variable) and 16,392 features as X matrix 
(a molecular entity with a unique m/z and retention time as measured by an 
LC-MS instrument). This study was conducted according to the guidelines 
laid down in the Declaration of Helsinki and all procedures involving human 
subjects were approved by the Regional Ethics Review Board in Uppsala 
(log no. 2008:040). Written informed consent was obtained from all subjects.  
‘Mosquito’: This dataset has been described in detail by Buck et al. (2016). 
Anopheles gambiae mosquitoes were collected from three villages in western 
Burkina Faso and whole-body bacterial flora was analyzed by 16S amplicon 
sequencing. In total, 29 observations were available for village of capture 
(categorical Y variable; three levels) and 1678 16S operational taxonomic 
units (OTU, X matrix). However, owing to the non-continuous nature of 16S 
data, leading to a high degree of data scarcity, 940 OTUs showed near-zero 
variance. PLS was therefore performed on a subset with 738 OTUs only.  
‘Crisp’: The study design is described elsewhere (Zamaratskaia et al., 2017, 
accepted). In brief, rye and wheat crisp breads were consumed as part of 
isocaloric breakfast interventions in a cross-over design. Untargeted 
UHPLC-qTOF-MS metabolomics was performed on plasma samples from 
20 randomly selected individuals and six time points. Feature signals were 
numerically integrated using the trapezoidal rule to obtain area-under-the-
44 
 
curve values (AUCs) for all features. This dataset contained 20 subjects (Y, 
ID) and AUCs of 1587 features as X matrix.  
3.2 Untargeted LC-MS metabolomics 
3.2.1 Analytical platform and data acquisition 
Untargeted LC-MS metabolomics was performed on the plasma samples of 
participants selected from the VIP cohort, as described in section 3.1.1.  
Sample preparation: Fasting heparin-plasma samples (90 µL) were mixed 
with 360 µL acetonitrile, incubated in a 96 deep well polypropylene plate in 
an ice bath for 15 min and then centrifuged at 1200 g for 5 min through a 0.2 
µm polytetrafluoroethylene filter to collect the filtrate. The filtrate was kept 
refrigerated at 4 ℃ until further analysis.  
Quality controls: Two types of independent biological samples (QC-A: 
batch-specific quality control sample; QC-B: long-term reference sample) 
were used to monitor the stability and functionality of the system throughout 
the instrumental analyses and together constituted approximately 16% of 
analytical samples.  
Data acquisition: For hydrophilic interaction (HILIC) chromatography, 3 
µL plasma were injected for analyses. An Acquity UPLC BEH Amide 
column (2.1 x 100 mm, 1.7 mm; Waters Corporation) was used and 
maintained at 45 ℃ for separation. The mobile phase was delivered at 600 
µL/min and consisted of 50% acetonitrile (vol:vol; eluent A) and 90% 
acetonitrile (vol:vol; eluent B), both containing 20 mmol/L ammonium 
formate (pH 3), delivered in a gradient profile: 0-2.5 min: 100% B, 2.5-10 
min: 100 to 0% B, 10-10.01 min: 0 to 100% B, 10.01-12.5 min: 100% B. For 
reversed phase (RP) chromatographic analyses, 4 µL plasma were injected. 
Separation was performed using a Zorbax Eclipse XDB-C18 column (2.1 x 
100 mm, 1.8 mm; Agilent Technologies) at 50 ℃. The mobile phase was 
delivered at 400 µL/min and consisted of eluent A (water, Milli-Q purified) 
and eluent B (methanol), both containing 0.1% (vol:vol) of formic acid, 
delivered in a gradient profile: 0-10 min 2 to 100% B, 10-14.5 min: 100% B, 
14.5- 14.51 min: 100 to 2% B, 14.51-16.5: 2% B.  The electrospray 
ionization (ESI) source was operated for both positive mode (+) and negative 
(-) ionization. The approach used in MS/MS analyses has been described 
elsewhere (Hanhineva et al., 2015).  
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In total, samples including QCs were analyzed in eight batches, with 
randomization being constrained to having sample pairs and repeated 
samples within the same batch, and otherwise full randomization within 
batch (Figure 8). Instrumental analyses were performed with approximately 
250 injections per batch in eight analytical batches over six months. 
Figure 8. Analytical protocol for untargeted LC-MS metabolomics.  
In total, for each sample, four spectra were obtained from reversed phase 
(RP, ESI+), RP (ESI-), hydrophilic interaction chromatography (HILIC 
ESI+), HILIC (ESI-) and were subjected to data processing. 
3.2.2 Data processing  
Data processing comprised three steps: spectral processing, data 
normalization, and putative feature annotation and aggregation (Figure 9).  
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Figure 9. Overall workflow for untargeted LC-MS metabolomics data processing used in this 
thesis. The number of features retained after each step of processing is presented. HILIC:  
hydrophilic interaction (HILIC) chromatographic analysis; RP: reversed phase chromatographic 
analysis. 
Specifically, spectral processing was conducted using feature detection 
and alignment algorithms with optimized parameters implemented in XCMS 
(Scripps Center for Metabolomics, La Jolla, CA). Raw data files were 
converted to mzXML format using MassHunter Qualitative Analysis 
B.06.00 (Agilent Technologies) and were subjected to XCMS following 
standardized procedures (Smith et al., 2006). The centWave algorithm was 
used for peak detection. Parameters were optimized by iterative testing of 
different settings of parameter configurations and IPO packages (Libiseller 
et al., 2015). The quality of algorithm performance was evaluated by the 
number of detected features and visualizing plot of detected peaks. 
Optimization of main parameters was conducted for each mode separately 
(Table 2). 
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Table 2. Optimized parameters applied for untargeted LC-MS spectral processing 
     
Parameter Chromatography and ionization mode 1 
 HILIC (+) HILIC (-) RP(+) RP (-) 
XCMS 2 
snthresh 6 6 6 6 
ppm 15 15 15 15 
prefilter (3,1000) (3,1000) (3,1000) (3,1000) 
Peakwidth (5,20) (5,20) (5,76) (5,84) 
mzdiff 0.0056 0.005 0.0045 0.0045 
gapInit 0.928 0.296  0.58 
gapExtend 2.688 2.4  2.19 
bw 1.5 1.5 30, 10, 5 * 2 
batchCorr 3 
mzdiff 0.005 0.005 0.005 0.005 
rtdiff 10 15 10 15 
Fold change limit 5 5 7 5 
PUTMEDID-LCMS 4 
ppm mass error 10 10 10 10 
Retention time  shift 2.5 2.5 2.5 2.5 
Retention time  range 30 - 720 seconds 70-980 seconds 
1RP: Reverse phase chromatography; HILIC: hydrophilic interaction chromatography. ‘+’ or ‘ –’ denotes the 
electrospray ionization, positive or negative, respectively. 2Freely available software implemented in R was 
applied for data deconvolution. Retention time correction was achieved using the Obiwarp function for HILIC 
(ESI+), HILIC (ESI-), and RP (ESI-) and the LOESS fitting method was used for RP (ESI+). snthresh: signal to 
noise ratio; ppm: measurement error; prefilter: prefiltering step for the first analysis step (ROI detection), mass 
traces are only retained if they contain at least 3 peaks with intensity >= 1000; peakwidth: the expected 
approximate peak width in chromatographic space, given as a range (min, max) in seconds; mzdiff: the minimum 
difference in m/z dimension for peaks with overlapping retention times; gapInit and gapExtend : penalty for gap 
opening and gap enlargement, respectively; bw: the bandwidth (standard deviation of the smoothing kernel) for 
alignment. 3The developed ‘batchCorr’ (Paper I) was used for within- and between-batch correction. rtdiff is 
equal to retention time deviation of samples in 8 batches. 4A freely available workflow for putative annotation 
of metabolites or metabolite groups (http://omictools.com/putmedid-lcms-tool). *Peak group retention time 
correction and alignment were performed with different bandwidth setting iteratively.  
The data processing procedures developed in Paper I were applied for batch 
misalignment correction, within-batch cluster-based drift correction, and 
between-batch signal intensity normalization. The algorithms of the 
procedures are available as an R package ‘batchCorr’ (see chapter 4.1 of this 
thesis for detailed description of algorithms). The parameters used are given 
in Table 2.  
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PUTMEDID-LCMS Workflow was applied to group features potentially 
resulting from one metabolite (Table 2). This procedure was performed 
batch-wise for each analytical mode. For each feature, qualified putative 
annotation was determined only if the same annotation was given for at least 
in five batches. For features that were determined originally from one 
metabolite, intensities were then aggregated. 
In total, 29,240 features were considered qualified (Figure 9) and thus 
were subjected to further statistical analyses in two endpoint studies (Papers 
III and IV).  
3.3 Statistical analysis 
All analyses were carried out using R v.3.4.0, except for intra-class 
correlation (ICC), which was calculated using a SAS macro ‘%ICC9’ freely 
available at https://www.hsph.harvard.edu/donna-spiegelman/software/icc9/ 
(SAS Institute, USA).  
3.3.1 Paper I  
Clustering of variables in the observation space was analyzed by the ‘mclust’ 
algorithm (Fraley et al., 2012). Principal component analysis (PCA) was 
performed on the data to assess the within- and between-batch drift 
correction.  
3.3.2 Paper II 
The R packages used included ‘mixOmics’ for PLS core modeling (Rohart 
et al., 2017), ‘randomForest’ for RF core modeling (Liaw and Wiener, 2002), 
‘Boruta’ (Kursa, 2010) and ‘VSURF’ (Genuer et al., 2015). For fitness 
estimation, Q2 was used for regression analysis, while number of 
misclassifications was used for classification and multilevel analysis. 
Permutation-based p-values were used for assessing modeling performance 
(Lindgren et al., 1996) by calculating the cumulative (1-tailed) probability 
of actual model prediction performance versus distribution of random 
permutations using standard Student’s t distribution or Student’s t test on 
rank-transformed data for nonparametric tests. 
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3.3.3  Paper III 
The overall workflow for discovery of predictive metabolites of developing 
type 2 diabetes is shown in Figure 10. To select informative features with 
minimal risk of model over-fitting, the novel statistical framework for 
multivariate modeling developed in Paper II was applied on the plasma 
metabolome. These algorithms are available as an R package (‘MUVR’). 
Development of these algorithms is described in detail in Chapter 4.2 of this 
thesis. 
Figure 10. Overall workflow for statistics used in Paper III. Number of features retained at each 
step is presented. 
Specifically, sparse PLS was performed as a pre-filter on the entire data 
to remove the majority of redundant features and/or features that were 
unlikely to contribute to discrimination between cases and controls. The 
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algorithm Multilevel PLS (ML-PLS) implemented in R package ‘MUVR’ 
(developed in Paper II) was performed on pre-filtered data to determine a 
parsimonious set of discriminative features ranked according to their 
importance. Top-ranked features, i.e. where the variable importance ranking 
score <100 (lower score indicates higher importance of a given feature to 
discriminate between cases and controls) were subjective to identification 
(see details in section ‘Metabolite identification’) and further analysis. 
Conditional logistic regression (R package ‘survival’) (Therneau and 
Lumley, 2017) was applied to investigate associations between metabolites 
at baseline and likelihood of developing T2D. Odds ratios (OR) were 
calculated for quartiles and per SD) increment based on a crude model and 
multivariate adjusted models controlled for traditional risk factors and/or 
lifestyle-related factors. To compensate for multiple testing, false discovery 
rate (FDR)-adjusted p-values were calculated and significance threshold was 
set at p<0.05.  
Reproducibility of metabolites was estimated by ICC over the 10-year 
period between the two sampling occasions among the subset of healthy 
participants (n=187). Systematic changes in metabolites over the 10-year 
period in relation to the time of diagnosis among the subset of T2D cases 
(n=187) were investigated by mixed model.  
Incremental predictive ability of metabolites was assessed using two 
approaches: i) by adding predictive metabolites to predefined traditional risk 
factors (covariates used in conditional logistic regression); or ii) through 
selection of optimal variables from traditional risk factors and/or metabolites 
using a validated random forest algorithm (Buck et al., 2016). For models 
based on approach ii), the metabolite score (MS) was based only on selected 
variables from the annotated predictive metabolites (MSI 1-2 level), the 
traditional risk score (TS) was based on 14 known traditional risk factors of 
type 2 diabetes, and the combined score (CS) was based on optimal variable 
selection among both metabolites and traditional risk factors. The area under 
the receiver operation characteristics curve (AROC, R ‘pROC’) was 
computed to evaluate the prediction performance of different models. 
Incremental prediction performance of MS compared with traditional risk 
factors was further assessed by net reclassification improvement (NRI) and 
integrated discrimination improvement (IDI) tests (R package 
‘PredictABEL’ (Kundu et al., 2011). 
Spearman correlation coefficients were calculated to explore the 
association of metabolites with traditional risk factors at baseline among 
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healthy participants (n=503). Partial Spearman correlations were calculated 
to investigate independent associations between each of the metabolites with 
HOMA-IR and HOMA beta cell function (HOMA B%), adjusted for BMI, 
age, sex, and case/control status among 187 case/control pairs with follow-
up samples. 
3.3.4 Paper IV 
The overall workflow for identification of metabolites related to pre-defined 
indices and their associations with likelihood of developing T2D are shown 
in Figure 11.  
52 
 
Figure 11. Overall workflow for statistical analysis in Paper IV. Number of features retained at each step is 
presented. AR 19:0-Gln, nonadecyl-benzenediol glucuronide; CMPF, 3-carboxy-4-methyl-5-propyl-2-
furanpropionic acid; TMAO, trimethylamine N-oxide.  
The RF core modelling implemented in R package ‘MUVR’ (Paper II) 
was performed on sparse PLS pre-filtered data to discover index-related 
features. Direct associations between features retained from random forest 
and indices were assessed using partial Spearman correlation analysis 
controlled for case-control status, age at blood draw, gender, BMI (kg/m2), 
smoking status, education, and physical activity.  
Odds ratios and reproducibility of index-related metabolites were 
assessed as in Paper III. Metabolite patterns were derived from identified 
index-related metabolites using PCA (R package ‘psych’) (Revelle, 2017). 
Correlations between scores and dietary variables, i.e., indices and individual 
foods reported in both FFQs and with <0.5% missing values, were 
calculated. Prediction performance of risk modeling for PCA score was 
assessed using AROC.  
Associations with T2D risk were also assessed for 10 a priori-defined 
metabolites previously associated with either a healthy Nordic dietary pattern 
or with foods captured by Nordic dietary indices. 
3.4 Metabolite identification  
Metabolites were identified based on accurate mass and MS/MS 
fragmentation manually matched against an in-house library of authentic 
standards, online databases, and the literature. The confidence level of 
annotation was categorized according to the Metabolomics Standard 
Initiative (MSI) (Sumner et al., 2007).    
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4.1 ‘batchCorr’ for data processing 
The data-processing pipeline for untargeted LC-MS metabolomics 
developed in Paper I is available as an open source R package ‘batchCorr’ 
(https://gitlab.com/CarlBrunius/batchCorr). It includes multiple algorithms 
to overcome the measurement errors inherent to variations in signal intensity 
and shifts in m/z and RT between samples in untargeted LC-MS 
metabolomics data. 
4.1.1 Feature alignment between multiple batches 
When applying XCMS for grouping and alignment of multiple-batch data, 
low bandwidth may capture batch-specific features but result in missing data. 
As one of the standardized procedures in XCMS, forced integration data 
filling, i.e., ‘fillPeaks’, is often applied following feature alignment. 
However, there is an obvious risk of splitting one true feature into two or 
more, thereby artificially creating batch-specific features and increasing 
noise in the variable set (Figure 12). On the other hand, increasing bandwidth 
for alignment may introduce the risk of forcing alignment of unrelated 
features, consequently increasing the information loss.   
To overcome this problem, an algorithm for misalignment correction was 
developed (Figure 13). Datasets should be first examined for systematic 
feature misalignment between batches to avoid loss of data integrity.
4 Results and discussions 
54 
 
Figure 12. Strategies to deal with missing data resulting from systematic misalignment across batches exemplified in the retention time (rt) domain. Increasing 
bandwidth setting to capture all batches (black lines) introduces the risk of forcing alignment of unrelated features. Lower bandwidth settings can accurately capture 
batch-specific features (dashed blue, whole green or dot-dashed red), but may result in missing data after peak picking. Forced filling will insert mostly baseline 
noise (approx. zero areas) into the peak table, whereas imputation will provide estimates of the true values. Batch alignment will provide the possibility to aggregate 
batch-specific features to their global counterparts.  
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Figure 13. Algorithm developed for between-batch feature alignment involved in ‘batchCorr’. 
Flowchart for alignment of features systematically misaligned between batches. aA feature is 
considered a potential candidate for alignment if 0<total batch presence<number of batches. 
bPotential candidates for alignment are considered similar if m/z and retention time (RT) are within 
user-defined tolerance. cCandidates are considered for alignment and subsequently clustered if not 
mutually present in the same batch (i.e., presence vector orthogonality). dClusters containing 
multiple possible alignments are recursively subdivided into sub-clusters.   
In brief, presence/missingness of each feature is first aggregated per batch 
to filter out spurious random noise or erroneous misalignment of individual 
samples. Potential alignment candidates are features present in at least one, 
but not all, batches.   
Second, for each potential candidate, correspondence with other 
candidates (‘events’) is determined if features are sufficiently close in the 
m/z and RT domains (i.e., within user-defined borders) and under the 
constraint of batch presence being orthogonal between features, i.e., ensuring 
that two features present in the same batch cannot be aligned. Key parameters 
are mzdiff and rtdiff, representing a user-defined box bounded by largest 
allowed absolute m/z and RT differences, where mzdiff is set according to 
instrument resolution and rtdiff was chosen as the maximum retention drift 
between batches obtained from XCMS.  
Third, all distinct events thus consist of two alignment candidates. Events 
which share common alignment candidates are then clustered. If all cluster 
candidates are mutually orthogonal, correspondence is assumed and 
alignment candidates are then merged. When multiple alignment 
combinations occur, multiple alignment candidates are disentangled into 
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their respective correspondences through a recursive sub-clustering 
algorithm.  
4.1.2 Within- and between-batch feature intensity normalization 
The algorithm for within-batch drift correction consists of four essential 
parts: clustering of features; drift modelling per cluster; drift correction per 
cluster; and removal of individual features with poor reproducibility (Figure 
14a). The cluster-based strategy can increase within-batch data quality 
(Figure 15), while minimizing the risk of over-fitting (e.g., modeling of noise 
in individual features, e.g., QC-LOESS (Dunn et al., 2011)) by adding 
statistical strength of multiple features to the individual cluster regressions. 
Note that the availability of two distinct QC samples, i.e. QC-A and QC-B, 
analyzed in the present thesis (see section 3.2.1) allowed unbiased measures 
to be applied for quality improvement using data correction techniques to 
avoid over-fitting and introducing bias. In the algorithm, drift correction per 
cluster was therefore performed only if providing an unbiased measure of 
increased quality of data measured on QC samples not used for drift 
modeling.  
Between-batch normalization is performed through an iterative process 
(Figure 14b). Batch-wise qualified data after alignment and within-batch 
drift correction are first limited to common features, i.e., those features 
common to all batches. Normalization is then achieved using either of two 
standard approaches: reference sample intensity or population-based 
(median) normalization. Normalization by average reference sample 
intensity per batch is performed only if the precision (as indicated by CV) 
and accuracy (deviation from general intensity ratio between batches) of the 
reference samples are within user-defined tolerances (e.g., CV<30% and fold 
change <5). Regardless of chromatography type and ionization modes, the 
severe batch effect among multiple batches clearly observed as the main 
determinant of variance prior to normalization was drastically reduced after 
applying the between-batch normalization procedure (Figure 16). 
It is noteworthy that the algorithms developed can be used either alone or 
in combination to suit any particular analytical situation. For example, 
correction of misalignment between batches is easily integrated with 
available sample-based alignment methods, e.g., obiwarp implemented in 
XCMS. The within-batch correction without alignment or normalization can 
be applied if samples are analyzed within only one batch. Moreover, in the 
case of multiple batches, these algorithms can easily be chosen at will, 
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combined with other drift correction and/or normalization procedures, and 
incorporated into a customized workflow.  
Figure 14. Algorithms developed for within- and between-batch signal intensity drift corrections. 
a) Flowchart of cluster-based within-batch intensity drift correction. aCluster quality is considered 
to be improved if rmsd(QC-B)with correction < rmsd (QC-B) without correction, where ‘rmsd’ denotes root 
mean squared distance from the cluster center point. In this algorithm, QC-A is used for drift 
modeling while QC-B is used for assessment of data quality improvement. b) Flowchart of 
between-batch intensity normalization algorithm. aFeatures were considered reproducible if 
reference sample intensity per batch CV < e.g., 30%. bReference sample average feature intensity 
ratios between batches were considered within limit if not deviating from corresponding average 
feature intensity ratios by more than a fold change of five. For features meeting both criteria, 
batches were normalized by average reference sample intensity. For other features, reference 
samples were not considered sufficiently representative of the sample population and features were 
thus normalized by median batch intensity. 
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Figure 15. Feature intensity drift before and after within-batch correction. Authentic QC features 
separated into different clusters (number of features ranges from 30 to 185). (a-f) depict different 
intensity drift behaviors. The clusters presented in a) and b) closely follow the general within-batch 
intensity drift, whereas the other clusters (c–f) represent several distinctly diverse drift patterns. For 
each cluster, the upper graph shows the scaled features in grey and the cluster drift function in 
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black. The lower half shows the same features on the same y scale after application of cluster-based 
drift correction. Signal variations as indicated by coefficient of variation were considerably reduced 
in clusters presented after with-batch normalization. 
Figure 16. PCA score plots for visualization of performance of between-batch normalization 
(BBN). Data from eight analytical batches of human plasma samples used for Papers III and IV 
are shown. Data obtained by hydrophilic interaction chromatography (HILIC) and reverse phase 
chromatography (RP) using both positive (ESI+) and negative (ESI-) ionization. Fold change of the 
ratio of average reference sample intensity for a specific feature measured in batches and the ratio 
for the average intensity of all features within the batches was 7 for RP (ESI+) and 5 for others. 
Batches A-H are presented in different colors. PCA scores of qualified feature intensities before 
and after BBN are shown as crosses and circles, respectively.  
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4.2  ‘MUVR’ for multivariate modelling 
A statistical validation framework for multivariate modelling was developed 
and is available as an open source R package ‘MUVR’ 
(https://gitlab.com/CarlBrunius/MUVR) (Paper II). MUVR incorporates an 
effectively unbiased variable selection process within an rdCV scheme and 
enables simultaneous identification of all-relevant variable sets and the 
minimal-optimal variable set (Figure 17). The algorithm developed allows 
for both PLS and RF core modeling and supports regression, classification, 
and multilevel modeling. 
4.2.1 MUVR principle 
Figure 17. Graphical representation of unbiased variable selection in the MUVR algorithm.  
The original data are randomly subdivided into OUTER segments. For each 
OUTER segment, the remaining (INNER) data are used for training and 
tuning of model parameters, including recursive ranking and backwards 
elimination of variables. In each of the INNER training models, variables are 
ranked by variable importance in projection for PLS analysis, whereas for 
RF analysis ranking is based on mean decrease in Gini index (classification) 
or mean decrease in accuracy (regression). For each iteration of the variable 
tuning, variable ranks are averaged between the inner models. After 
averaging, a user-specified proportion of the variables is removed from the 
data matrix before the next iteration (varRatio), where INNER segments are 
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again randomly sampled to decrease bias to individual segments. Model 
performance is then estimated from predictions of the untouched test 
segments, using the number of selected variables (and optimal number of 
components for PLS modeling) determined by a consensus model from all 
INNER observations. Arbitration of model performance in variable tuning 
within the inner validation loop is performed using different fitness functions 
specifically adapted to the problem type: Root mean square error of 
prediction for regression and number of misclassifications for multilevel or 
general classification analysis (two or more classes). The area under the 
receiver operation characteristics curve is also supported as an optional 
fitness metric for two-class discriminant analysis (Szymańska et al., 2012).   
The procedure is then repeated for improved modeling performance. 
These models are created nRep (number of repetitions) × nOuter (number of 
outer segments) times for prediction of test segment observations ensuring 
that test segment observations are never used for model training or tuning. 
For key parameters of MUVR, results of stability testing suggest having 
6nOuter8, nInner=nOuter-1, nRep≈15 and 0.5≤varRatio≤0.75 for initial 
preliminary analysis. Users could then increase nRep≥50 for reproducible 
results.  
4.2.2 MUVR performance  
The MUVR algorithm was performed on three -omics datasets with different 
characteristics, i.e., ‘Freelive’ data used for regression analysis, ‘Mosquito’ 
data for classification analysis, and ‘Crisp’ data for multilevel analysis. The 
predictive results are shown in Figure 18(a-c). Regardless of the problem 
type (i.e., regression, classification, multilevel) and core modeling applied 
(i.e., PLS and RF), it was observed that variable reduction from the entire 
data to the ‘max’ model effectively resulted in removal of noise until an 
optimal validation performance as measured by the fitness function was 
obtained (Figure 18 d-f). The ‘max’ model would be an all-relevant solution, 
corresponding to a maximum of biologically relevant information and 
containing both optimal and redundant variables, and could be used to get an 
overview of biological perturbations or metabolic regulations associated 
with the research question. Further variable reduction from the ‘max’ model 
maintained validation performance down to the ‘min’ model, indicating 
dismissal of informative but redundant variables. Thus, the ‘min’ model 
corresponds to the minimal-optimal variable set, useful e.g., for biomarker 
discovery. Further variable reduction increased model prediction errors, 
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however, probably due to elimination of genuinely relevant, non-redundant 
information. 
Figure 18. Predictive results and validation of models conducted for three datasets using MUVR 
PLS (left) and random forest (right) core modeling: (a-c) Predictive results of ‘mid’ model. a) 
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Regression using ‘Freelive’ data. Prediction estimates are shown in grey for each repetition, and in 
black for the prediction estimates averaged over all repetitions. b) Classification using ‘Mosquito’ 
data. Each swimlane represents one observation. Class probabilities are color-coded by class and 
presented per repetition (smaller dots) and averaged over all repetitions (larger dots), with 
misclassified samples circled. c) Multilevel analysis using ‘Crisp’ data. Samples are matched row-
wise between upper and lower half for the positive and negative effect matrix, respectively. All 
upper half predictions should be negative and all lower half predictions positive for ideal 
classification. Prediction estimates are shown in grey for each repetition, and in black for the 
prediction estimates averaged over all repetitions and misclassified samples circled. (d-f) MUVR 
validation plots for identification of the all-relevant (‘max’ model) and minimal-optimal (‘min’ 
model) variables on three datasets. d) ‘Freelive’, regression; e) ‘Mosquito’, classification; f) ‘Crisp’, 
multilevel. 
Benefiting from the rdCV scheme, MUVR minimizes selection bias by 
performing variable selection and tuning of model parameters in the inner 
segments, followed by assessment of modeling performance using outer loop 
data that are held out of model construction and variable reduction. MUVR 
yielded parsimonious models with minimal over-fitting and improved model 
performance with rdCV, particularly in cases where PLS core modelling was 
applied (Figure 19). 
MUVR outperformed other RF-based variable selection techniques 
tailored for identification of all-relevant variables, i.e., Boruta and VSURF, 
in various aspects, e.g., less-stringent variable inclusion criteria, feasible 
computation time, minimum general over-fitting. It is also worth noting that, 
although Boruta and VSURF enable variable selection, some form of cross-
validation is still required to avoid selection bias and to assess prediction 
performance (Kursa, 2010) (https://m2.icm.edu.pl/boruta/). In this respect, 
MUVR is more easy and efficient to use, allowing for simultaneous variable 
selection and validation with minimized selection bias.  
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Figure 19. Performance of repeated double cross-validation models without (rdCV) or with 
unbiased variable selection (MUVR) built from actual data and random permutations for three data 
sets: a) ‘Freelive’, regression; b) ‘Mosquito’, classification; c) ‘Crisp’, multilevel. The performance 
distributions of random permutations are represented as violin plots, with the asterisks representing 
actual model performance (Q2 for regression, number of misclassifications for classification and 
multilevel analysis). 
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4.3 Plasma metabolites associated with risk of T2D 
In Paper III, several predictive metabolites of T2D were identified. These 
metabolites had limited incremental value in risk prediction beyond optimal 
utilization of traditional risk factors. However, they may provide other 
advantages over traditional risk factors, through higher long-term stability 
and their potential in providing information related to disease 
pathophysiology and progression.  
4.3.1 Plasma metabolites associated with risk of developing T2D 
Forty-six predictive metabolites of T2D were identified, including novel 
findings, i.e., phosphatidylcholines (PCs) containing odd-chain fatty acids 
(OC-FA) and 2-hydroxyethanesulfonate, and previously identified 
predictive biomarkers. Of these, 41 were associated with insulin resistance 
and/or β-cell dysfunction at baseline. Among the 46 metabolites, 26 showed 
intermediate to good reproducibility among healthy controls 
(0.4≤ICC≤0.75), reinforcing their potential as predictive biomarkers.  
Novel findings regarding PCs containing OC-FAs are encouraging 
enough to merit further investigation. It was found that lysoPC(19:1), 
lysoPC(15:1) and PC(15:1/18:2) were inversely associated with risk of 
developing T2D and exhibited moderate to high long-term reproducibility 
(ICC>0.4). Moreover, the three lipids changed in the disease-associated 
direction at follow-up measurement, thus most likely representing disease 
progression. 
Paper III also replicated findings from several previous studies and 
supports existing hypotheses in relation to T2D pathogenesis, e.g., 
dysregulated lipid metabolism (Markgraf et al., 2016; de Mello et al., 2017; 
Meikle and Summers, 2017), impaired BCAA metabolism (Chen et al., 
2016; Lotta et al., 2016), and abnormal DAG (diglyceride) accumulation 
(Markgraf et al., 2016). However, Paper III also provides information on the 
reproducibility of previously reported metabolites, an issue which has rarely 
been investigated previously. For instance, the remaining four PCs, i.e., 
lysoPC(18:2), lysoPC(17:0), lysoPC(20:1), and PC(16:0/16:1), had only 
weak to moderate long-term reproducibility (ICC<0.4), which limits their 
potential as predictive biomarkers. BCAAs and 3-methyl-2-oxovaleric acid 
had high long-term (10 years) reproducibility (ICC >0.6), similar to reported 
two-year ICCs (Carayol et al., 2015) but weaker shorter-term reproducibility 
(Floegel et al., 2011; Breier et al., 2014).  
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4.3.2 Improved risk prediction with optimal variable selection 
For the first time, by adopting an unbiased variable selection approach 
among study-specific traditional risk factors and/or metabolites (Figure 20a), 
results from the comprehensive predictive analyses illustrate that predictive 
metabolites can provide complementary information, albeit with limited 
predictive improvement beyond the optimal utilization of traditional risk 
factors (Figure 20b).  
Figure 20. Comparison of the prediction performance of clinical risk factors, metabolites, and their 
combinations for risk of type 2 diabetes. a) Optimally selected subset of predictors, employing a 
validated random forest algorithm, for metabolite score (MS), traditional risk score (TS), and 
combined score (CS). b) Prediction performance of different models trained from metabolites, 
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traditional risk factors, and their combinations. The area under the receiver operation characteristics 
curves (AROC) was obtained from 10,000 models where the samples were randomly split into 
training (60%) and test sets (40%) for prediction and validation. Model 1 included fasting plasma 
glucose (mmol/l) and BMI (kg/m2) as predictors; Model 2 further included physical activity, 
education, smoking, alcohol, dietary fibre, red and processed meat consumption (g/day), and coffee 
intake as predictors; 2h-PG: 2h plasma glucose. DAG: diglycerides. FPG: fasting plasma glucose. 
PC: Phosphatidylcholine. 
Several prospective studies have assessed the incremental predictive 
utility of adding metabolite biomarkers to traditional risk factors (Figure 21). 
These studies all used either an established risk score as reference or pre-
defined subset of traditional risk factors as covariates adjusted in prediction 
models. Adding metabolites improved AROCs by 0.4-16% (Figure 21, blue 
bars).   
In a majority of studies, traditional risk factors have not been optimally 
selected, which may under-estimate the predictive power of such risk factors 
in cohorts. This may give an overly optimistic impression of the benefits of 
adding metabolite data in risk prediction models, as clearly supported by the 
finding that adding best predictive metabolites (MS) into models constructed 
using pre-defined risk factors improved risk prediction by about 4% (Figure 
21, red bar). However, compared with a model based on optimal selection of 
available cohort-specific traditional risk factors, only about 2.5% 
improvement was achieved (Figure 21, black bar). A larger improvement (6-
8%) came, in fact, from optimal selection of traditional risk factors compared 
with pre-defined risk factors (Figure 21, yellow bars).  
Many of the risk predictors typically used in cohort studies, e.g., single 
measurements of blood lipids, blood pressure, and dietary data from FFQ, 
suffer from large systematic and random errors, which in turn may lead to 
inaccurate risk estimates (Tirosh et al., 2008). Combined scores (CS) 
represented the optimal integration of metabolite predictors and traditional 
risk factors, which showed comparable predictive ability to Traditional risk 
scores (TS). However, the selected metabolite predictors in CS showed 
higher long-term reproducibility (0.37≤ICC≤0.68) than the total cholesterol, 
systolic blood pressure, and red/processed meat (0.3≤ICC≤0.41) involved in 
TS. This finding suggests that, although additional metabolite biomarkers 
may provide little improvement in prediction performance, reproducible 
metabolites may under some conditions serve as a complement or alternative 
to established risk factors, most likely providing more accurate risk 
estimates.   
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Figure 21. Incremental predictive ability of metabolites added to traditional risk factors. Area under 
the receiver operation characteristics curve (AROC) difference% was calculated by (AROC of 
modeltraditional risk factors+ metabolites – AROC of modeltraditional risk factors)/AROC of modeltraditional risk factors 
×100%. Model 1 and Model 2 are models conducted using a priori-selected traditional risk factors. 
TS: Traditional risk factor score. Black bar denotes the additional predictive ability of metabolites 
beyond TS. Yellow bars denote the AROC difference% between TS and Model 1/2.  
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4.4 Metabolites related to healthy Nordic dietary indices 
and risk of T2D  
In Paper IV, metabolites related to predefined healthy Nordic dietary indices 
were identified and their associations with risk of T2D were investigated. 
The results did not support any association between indices and risk of T2D. 
Rather, unhealthy foods not included in the indices, such as pizzas, snack, 
liquor, and hamburgers, were associated with increased risk in the VIP 
population. 
4.4.1 Metabolites related to BSDS and HNFI 
In total, 29 metabolites were associated with Baltic Sea Diet Score (BSDS) 
(-0.22<r<0.21) and 13 with Healthy Nordic Food Index (HNFI) (-0.14<r< 
0.17). Correlations were in the same range as previously reported for BSDS 
and other established healthy dietary pattern indices, e.g., the Healthy Eating 
Index and the WHO Healthy Diet Indicator(Playdon et al., 2017). Among 
these metabolites, only four were associated with both indices, which is most 
likely attributable to the different food items used to score adherence 
(Playdon et al., 2017).  
The associations between metabolites and indices are not easily 
interpreted: some of the index-related metabolites could be biomarkers of 
particular food items that were key contributors to the indices investigated, 
e.g., fish (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) 
(Marckmann and Lassen, 1995; Silva et al., 2014) and whole-grain products 
(pipecolic acid betaine) (Hanhineva, Lankinen, et al., 2015; Pekkinen et al., 
2015). However, the majority of metabolites were associated with multiple 
foods captured by the indices as well as foods that were not (Figure 22). 
Thus, index-related metabolites may be related to general lifestyle patterns, 
which may possibly reflect the co-consumption of different foods (Lloyd et 
al., 2013; Guertin et al., 2014; Playdon et al., 2017), or metabolites formed 
endogenously in response to dietary/lifestyle exposures (Esko et al., 2017). 
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Figure 22. Correlations between index-related metabolites, healthy Nordic dietary indices, and food categories. *** p<0.00001, ** p<0.0001, * p<0.001,. 
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4.4.2 Healthy Nordic dietary indices and risk of T2D 
No association was found between a priori-defined healthy Nordic dietary 
indices and T2D risk. This was surprising, given the beneficial 
cardiometabolic effects shown for healthy Nordic dietary patterns and/or 
food items in dietary intervention studies and previous observational studies 
(Adamsson et al., 2011; Uusitupa et al., 2013; Khakimov et al., 2014; 
Lankinen et al., 2014; Roswall et al., 2015).  
Fish is a central food item in the indices investigated. However, it was 
found that established biomarkers of fish consumption, i.e., EPA and DHA, 
were positively associated with T2D risk, although attenuated on adjustment 
for BMI and blood lipids. This association may be due to the presence of 
organic pollutants known to occur in fish from the Baltic Sea (Mackenzie et 
al., 2004; Järv et al., 2017), which have been positively associated with T2D 
(Marushka et al., 2017). The pollutants may counteract health effects of 
DHA and EPA on T2D risk (Marushka et al., 2017). In contrast, several 
metabolites that were related with whole grains and fruits were inversely 
related with T2D (Parker et al., 2013; Marushka et al., 2017; Schwingshackl 
et al., 2017).  
Index-related metabolites were analyzed by PCA and the self-aggregated 
metabolites (loadings) were co-visualized with dietary variables and ORs of 
T2D in a ‘Triplot’, to aid in the interpretation of dietary patterns and risk of 
developing T2D (Figure 23a). The results clearly showed that indices and 
most food components of indices, with the exception of whole grains, were 
not associated with T2D risk in this case. Specifically, PC1 was indicative of 
adherence to healthy Nordic dietary indices, but was not associated with T2D 
(Figure 23b). In contrast, index-related metabolites with higher loading in 
PC2 were primarily associated with foods not included in the indices, i.e., 
pizza, hamburgers, snacks. The observation that risk was predominantly 
associated with an unhealthy, rather than healthy, diet is supported by several 
other studies that have applied data-driven methods (e.g., PCA, cluster 
analysis and reduced rank regression) (Jannasch et al., 2017).  
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Figure 23. Associations between diet, index-related metabolites, and risk of developing type 2 
diabetes (T2D). a) ‘Triplot’ representing index-related metabolites analyzed by PCA and 
correlations between principal component (PC) scores with dietary variables (individual foods in 
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blue circles and dietary indices in purple circles) and odds ratios (ORs) of T2D (per standard 
deviation; 95% confidence interval; red squares). Metabolites were visualized if |loading| ≥0.4. 
Correlations between PC scores and dietary variables were visualized if |correlation coefficient| 
≥0.15 at a Bonferroni-adjusted p<0.05. ORs were obtained from crude model and model adjusting 
for lifestyle-related factors, fasting plasma glucose (mmol/L), BMI (kg/m2), total cholesterol 
(mmol/L), triglycerides (mmol/L), and systolic and diastolic blood pressure (mmHg). For simple 
interpretation, metabolites, individual foods, and ORs along the same axis in the plot are associated. 
Dietary indices are orthogonal to ORs and therefore not associated with T2D risk. Receiver 
operating characteristics curve of b) PC1 and c) PC2 with the AUC (95% CI) for predicting incident 
T2D. 
4.4.3 Replication of previously reported metabolites and T2D risk 
Associations between 10 metabolites that were identified in recent literature 
to be associated with exposure to healthy Nordic foods and T2D risk in this 
study population were also investigated.  
The findings reinforce the potential of using CMPF and 3-carboxy-4-
methyl-5-pentyl-2-furanpropionic acid as biomarkers for fish intake 
(Hanhineva et al., 2015; Koppe and Poitout, 2016; Savolainen et al., 2017), 
AR 19:0-Gln for whole grains (Hanhineva et al., 2015), and threonate for 
vegetable and fruits (Table 3). However, none of these was associated with 
T2D risk.  
Moreover, no evidence was found to support claims for 1-methylhistidine 
and the two carnitines as generic biomarkers of fish and meat intake (Cheung 
et al., 2017). However, these two acyl-carnitines with good long-tern 
reproducibility were strongly associated with increased risk of T2D. 
Although the mechanisms remain unclear, increased concentration of acyl-
carnitines may be attributed to perturbed endogenous metabolism, e.g., 
abnormal mitochondrial fatty acid oxidation, which may interfere with insulin 
sensitivity, contributing to the development of T2D (Schooneman et al., 
2013).  
Table 3. A priori-selected plasma metabolites and their associations with dietary indices in a nested 
case-control study in the Västerbotten Intervention Programme (VIP) cohort 
Metabolites1 r2 r3 OR per SD4 ICC5 
TMAO - - 0.97(0.86,1.1) 0.18 (0.07, 0.36) 
1-methylhistidine - - 1.17(1.01,1.35) 0.38 (0.27, 0.51) 
Propionylcarnitine - - 1.44(1.24,1.66) 0.59 (0.49, 0.68) 
2-
methylbutyroylcarnitine 
- - 1.03(0.9,1.18) 0.52 (0.41, 0.62) 
Threonate - Vegetables (0.13) 1(0.88,1.15) 0.21 (0.11, 0.38) 
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Hipputic acid - - 0.88(0.77,1) 0.33 (0.21, 0.47) 
Indolepropionic acid 0.15 Cabbage(0.13), 
carrot(0.12) 
0.81(0.7,0.93) 0.23 (0.12, 0.39) 
CMPF - Fish (0.19) 1.04(0.9,1.2) 0.46 (0.35, 0.57) 
3-carboxy-4-methyl-5-
pentyl-2-furanpropionic 
acid 
- Fish (0.11) 1.09(0.95,1.24) 0.43 (0.32, 0.55) 
AR 19:0-Gln - WG bread (0.14) 0.99(0.87,1.12) 0.51 (0.40, 0.61) 
1Metabolites previously associated with either healthy Nordic diet or relevant individual food components, 
detected with MSI 1-2 in the present study. AR 19:0-Gln, nonadecyl-benzenediol glucuronide; CMPF, 3-
carboxy-4-methyl-5-propyl-2-furanpropionic acid; TMAO, trimethylamine N-oxide.  
2Partial Spearman correlation coefficients between metabolites and dietary indices or individual food 
components, controlling for age, gender, case/control status, BMI (kg/m2), smoking status, education, and 
physical activity.   
3Partial Spearman correlation coefficients between metabolites and individual food components. 
4Odds ratios (OR) per SD increment (95% confidence interval) of metabolites based on results from crude 
conditional logistic regression models. 
5Intraclass correlation coefficient, representing long-term reproducibility of metabolites among healthy 
controls (N=187) over 10 years.  ICC ≥0.4 denotes moderate to high reproducibility. 
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Untargeted metabolomics has emerged as a promising approach to address 
various research questions (Rochat, 2016; Dudzik et al., 2017; Han et al., 
2017). Although a wealth of analytical techniques and computational tools 
exist within the community, intuitive interpretation of complex data from 
untargeted metabolomics studies remains a major challenge, limiting 
translation of instrument-based results into biologically relevant conclusions 
(Alonso et al., 2015; Ren et al., 2015; Dudzik et al., 2017). In an effort to 
improve the overall quality of the untargeted metabolomics data, to reduce 
false positive discoveries and to promote accurate interpretation, two freely 
available R packages, i.e., ‘batchCorr’ (data-processing strategy) and 
‘MUVR’ (multivariate statistical framework) were developed (Papers I-II). 
These packages allow for ease of implementation and use in large-scale 
applications, including over 2000 samples and spectra from RP (+), RP (-), 
HILIC (+), and HILIC (-) per sample in the studies on which this thesis is 
based (Papers III-IV).   
Prospective cohort studies are particularly suitable for identification of 
early metabolic alterations before the onset of disease, since samples have 
been collected before diagnosis (Euser et al., 2009; Thiese, 2014). However 
untargeted metabolomics had been applied in very few prospective studies 
before the research in this thesis (Paper III; identification of predictive 
metabolites of T2D). In a large nested case-control study, several novel and 
previously identified predictive metabolites of T2D were found. Although 
predictive metabolites resulted in little improvement in prediction 
performance beyond optimal utilization of traditional risk factors, they 
provided useful information related to disease pathophysiology, e.g. 
dysregulated lipid metabolism, impaired BCAA metabolism, and abnormal 
DAG accumulation. Moreover, several metabolites have shown potential to 
reflect disease progression.  In addition, metabolites with good long-term 
5 General discussion 
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reproducibility may serve as a complement or alternative to established risk 
factors, most likely resulting in more accurate risk estimates.   
There is a large body of evidence from epidemiological studies, based on 
self-reported data, supporting an association between diet and the 
development of T2D.  Associations have been found for both specific food 
items and overall diet quality reflected by established healthy dietary indices. 
However, in this thesis metabolites that were identified as prominent 
predictive biomarkers of T2D (Paper III) were only weakly correlated with 
self-reported intake of individual foods (-0.1<r<0.13 among healthy 
participants after adjusting for confounders). In addition, although beneficial 
cardiometabolic effects have been shown for a healthy Nordic diet in several 
studies (Kyrø et al., 2013; Uusitupa, 2013; Kanerva et al., 2014), none of the 
top-ranking predictive metabolites was correlated with the two pre-defined 
healthy Nordic dietary indices, i.e., BSDS and HNFI. Moreover, the 
identified metabolites that were related to indices (Paper IV) showed 
remarkably weaker associations with T2D risk in the same population 
compared with the top-ranking predictive metabolites of T2D (Paper III).  
These findings imply that endogenous metabolic perturbations, e.g., 
dysregulated lipid metabolism, impaired amino acids metabolism and fatty 
acid metabolism might dominate the measurable metabolome, effectively 
drowning out systematic, but weaker, signals from dietary and lifestyle-
related metabolites in relation to disease. Predictive metabolites of T2D, such 
as BCAAs, carnitines, and phosphatidylcholines, that are repeatedly 
mentioned in the literature may be related to food intake to some extent, but 
their perturbations in relation to T2D may not be due to dietary exposures 
per se. Apart from genetic risk factors, the modifiable risk factors, in 
particular habitual unhealthy lifestyle, including poor diet quality, high 
energy intake, physical inactivity, smoking, and sleep disorders, are all 
contributors to dysregulated endogenous metabolism (Ley et al., 2016; Kolb 
and Martin, 2017).  
Although public health recommendations for overall lifestyle 
modification exist, precision lifestyle guidelines may be more effective for 
the prevention and treatment of T2D (Franks and Poveda, 2017; Mutie et al., 
2017). In this respect, more studies are required to disentangle the 
contributions of risk factors in pathological pathways of T2D.  State-of-the-
art multi-omics techniques and traditional methods should be integrated in 
order to provide comprehensive information, thereby facilitating meaningful 
optimization of lifestyle modifications. 
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In conclusion, the novel bioinformatics tools developed proved to be 
robust and effective to overcome vital data-analytical challenges inherent in 
large-scale untargeted metabolomics studies. The application of these tools 
assisted in discovering predictive biomarkers of T2D and biomarkers of 
healthy Nordic dietary indices in a Swedish population. Findings underline 
the potential of untargeted metabolomics for discovery of biomarkers, which 
may provide useful information related to disease pathophysiology and 
monitoring of disease progression, as well as facilitate investigations into the 
relationship between diet and risk of developing T2D. 
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 A novel data-processing strategy for large-scale untargeted LC-MS 
metabolomics data correction was developed (Paper I) and applied 
in the presented untargeted metabolomics studies (Papers III and 
IV).  
 A novel multivariate statistical framework for improving prediction 
performance and minimizing the risk of false positive discoveries 
was developed (Paper II) and applied to identify biomarkers of T2D 
and dietary indices (Papers III and IV).  
 Several fasting plasma metabolites were associated with risk of 
developing T2D, with moderate to excellent long-term 
reproducibility, reinforcing their potential as predictive biomarkers 
of T2D (Paper III).  
 Predictive metabolites can only provide limited improvement in 
T2D risk prediction beyond the optimal utilization of traditional risk 
factors in the Swedish population investigated (Paper III).  
 Heathy Nordic dietary indices, i.e., Baltic Sea Diet Score and 
Healthy Nordic Food Index, were not associated with T2D risk. 
Dietary patterns characterized by consumption of potentially 
unhealthy foods not included in these indices were derived from 
index-related metabolites and appeared to be more important for 
development of T2D in the study population (Paper IV). 
  
6 Concluding remarks 
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 It is worth conducting a more thorough comparison of the two 
algorithms developed in this thesis, i.e., ‘batchCorr’ and ‘MUVR’, 
with other existing software tools that have been proposed to address 
similar tasks.  
 MUVR can be further extended by implementing other core 
modeling techniques (e.g., support vector machine), variable 
ranking techniques (e.g., rank products), and/or different fitness 
functions (e.g., balanced error rate for classification problems with 
unbalanced design).  
 There is a pressing need for high-throughput bioinformatics tools to 
speed up and automate identification of metabolites from untargeted 
metabolomics experiments, thereby effectively increasing the 
number of certainly identified metabolites in relation to the total 
number of features captured. 
 On the basis of potential to improve identification strategy, all-
relevant metabolites should be identified, as they may provide a 
holistic review of early metabolite alteration before onset of T2D 
and facilitate mechanism investigation.  
 Other independent cohorts should be further investigated to 
generalize the conclusion that the incremental predictive ability of 
metabolites was limited in relation to optimal utilization of available 
traditional risk factors.  
 The association between healthy Nordic dietary indices and T2D risk 
merits further investigation in the entire VIP cohort or other 
independent population with high intake of Baltic fish. In this 
7 Future perspectives 
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respect, it is worth investigating the possible interactive effect of 
pollutants and fish consumption on T2D development. 
 Future studies should focus on optimizing recommendations for 
individuals with particular health needs and disease prevention, i.e. 
personalized lifestyle recommendations. To achieve this purpose, a 
proper integration of state-of-the-art multi-omics techniques and 
traditional methods should be conducted to investigate how lifestyle 
risk factors affect pathological pathways of T2D and prevent disease 
development, and to improve understanding of variability in 
individuals in responding to such lifestyle modifications.  
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